Edition:
United Kingdom

Innoviva Inc (INVA.OQ)

INVA.OQ on NASDAQ Stock Exchange Global Select Market

14.08USD
21 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$14.08
Open
$14.14
Day's High
$14.21
Day's Low
$13.95
Volume
160,249
Avg. Vol
260,961
52-wk High
$17.98
52-wk Low
$11.47

Chart for

About

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium... (more)

Overall

Beta: 2.23
Market Cap(Mil.): $1,420.09
Shares Outstanding(Mil.): 101.51
Dividend: --
Yield (%): --

Financials

  INVA.OQ Industry Sector
P/E (TTM): 9.84 28.28 30.39
EPS (TTM): 1.43 -- --
ROI: 50.15 12.94 12.61
ROE: -- 14.96 14.80

BRIEF-Innoviva Reports Q1 Adjusted Earnings Per Share $0.35

* Q1 EARNINGS PER SHARE VIEW $0.53 -- THOMSON REUTERS I/B/E/S

26 Apr 2018

Earnings vs. Estimates